Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, and Butler PC
Waist circumference is a reliable indicator of abdominal obesity, and it is considered a risk factor for ASCVD independent of body mass index [91]
Other important safety information Wegovy is FDA approved to treat weight loss in adults with a BMI of 30 or greater
If you're already on a prescription GLP-1 injection and swap to a patch, you could lose your progress and may need to restart from the lowest dose to avoid side effects
Participants who had lost an average of 10.6% of their body weight over 20 weeks on semaglutide were then split into two groups: continue the medication, or switch to placebo
What dietary changes should I make while taking the medicine